Microalbuminuria is a late event in patients with hypertension: Do we need a lower threshold?

Abstract

Insights

Vascular damage markers like increased intima-media thickness and arterial stiffness appear before microalbuminuria (MA) in hypertensive patients. These findings suggest a lower threshold for defining MA may improve early cardiovascular risk detection.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Hypertension Research

Background:

  • Microalbuminuria (MA) is a recognized marker of vascular damage.
  • Emerging evidence suggests increased cardiovascular risk at albuminuria levels below current MA definitions.

Purpose of the Study:

  • To investigate early cardiovascular alterations preceding the onset of MA in hypertensive individuals.
  • To assess subclinical vascular changes in hypertensive patients with varying left ventricular (LV) geometry.

Main Methods:

  • Assessed LV mass index, ambulatory arterial stiffness index, flow-mediated dilatation, and carotid intima-media thickness (IMT) in 150 hypertensive and 60 normotensive individuals.
  • Categorized participants into normotensive with normal LV geometry, hypertensive with normal LV geometry, and hypertensive with abnormal LV geometry.
  • Measured urinary albumin/creatinine ratio (UACR) from spot urine samples.

Main Results:

  • Hypertensive patients (Group II) showed increased arterial stiffness and IMT, and decreased flow-mediated dilatation compared to normotensive individuals (Group I), without differing MA levels.
  • These vascular changes were more pronounced in hypertensive patients with abnormal LV geometry (Group III).
  • MA significantly increased in Group III, and receiver operating characteristic analysis indicated MA (cut-off 19.25 mg/g) predicted increased IMT and abnormal LV geometry.

Conclusions:

  • Subclinical vascular changes, including increased IMT, reduced vasodilator function, and heightened arterial stiffness, precede MA and alterations in LV geometry.
  • These findings support the utility of a lower threshold for defining MA to identify early vascular damage.
  • Early detection of vascular changes before MA may allow for timely intervention in hypertensive patients.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
289
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
920
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
790
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
561
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434